Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome
Bioinformation · 31.10.2026 · 22 (10) · 6384-6389
DOI: 10.6026/973206300226384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Siddhi Tiwari.
Abstract (Originalsprache)
Megaloblastic anemia and myelodysplastic syndrome can present with overlapping macrocytic anemia and cytopenias but require distinct management. Therefore, it is of interest to evaluate the diagnostic utility of bone marrow examination in 120 patients, comprising 70 with megaloblastic anemia and 50 with myelodysplastic syndrome, using clinical, hematological, biochemical and marrow findings. Megaloblastic anemia accounted for 58.3% of cases, while myelodysplastic syndrome accounted for 41.7%; patients with myelodysplastic syndrome were significantly older (63.4 +/- 10.8 vs. 41.8 +/- 12.6 years; p
Zitieren
APA
Tiwari, S. (2026). Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome. Bioinformation, 22(10), 6384-6389. https://doi.org/10.6026/973206300226384
Vancouver
Tiwari S. Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome. Bioinformation. 2026;22(10):6384-6389. doi:10.6026/973206300226384
BibTeX
@article{Tiwari2026,
author = {Tiwari, Siddhi},
title = {Role of bone marrow examination in distinguishing megaloblastic anemia from myelodysplastic syndrome},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {6384--6389},
doi = {10.6026/973206300226384}
}
EUVIMED